Brief: Next Science Says Reaffirm FY24 Guidance For Revenue Of $36 Mln-$40 Mln
28/02/2024 01:33
Feb 28 (Reuters) - Next Science Ltd NXS.AX :
* REAFFIRM FY24 GUIDANCE FOR REVENUE OF US$36M-40M
* EXPECTS TO BE EBITDA AND CASHFLOW POSITIVE IN 2H FY24
Source text for Eikon: ID:nASX60n7m3
Further company coverage: NXS.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Next Science
See all newsBrief: ASX Says Next Science Limited Will Be Removed From Official List
Brief: Next Science Says CEO & Managing Director I.V. Hall, and CFO Marc Zimmerman Resigned
Brief: Next Science Releases Quarterly Activity Report
Australia's Next Science surges on sale of assets for $50 million
Brief: Next Science To Sell Majority Of Assets